05/23/2026
Breaking barriers in one of the toughest cancers.
We’re proud to spotlight groundbreaking research from Penn Vet that could transform how we treat pancreatic cancer.
By using lipid nanoparticles to reprogram CAR T cells inside the body, researchers are targeting the support system tumors rely on—effectively “melting away” the protective barrier that has long made solid tumors so difficult to treat.
This innovative approach not only shows promise in slowing tumor growth, but could also lead to safer, more accessible, and more cost-effective therapies—opening the door for CAR T success beyond blood cancers.
Because progress means finding new ways in—especially when the odds are toughest.
Read more via Penn Medicine News: https://penntoday.upenn.edu/news/targeting-tumor-supporting-cells-advancing-car-t-success-pancreatic-cancer